ACP
NVO

Aviance Capital Partners’s Novo Nordisk NVO Stock Holding History

Aviance Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371K Sell
10,086
-102
-1% -$4.83K 0.04% 278
2025
Q4 		$518K Sell
10,188
-500
-5% -$25.6K 0.06% 228
2025
Q3 		$593K Sell
10,688
-34,681
-76% -$2.03M 0.07% 217
2025
Q2 		$3.13M Buy
45,369
+33,798
+292% +$2.3M 0.41% 55
2025
Q1 		$803K Hold
11,571
– – 0.11% 167
2024
Q4 		$995K Sell
11,571
-5,520
-32% -$597K 0.14% 146
2024
Q3 		$2.04M Buy
17,091
+770
+5% +$103K 0.27% 93
2024
Q2 		$2.33M Buy
16,321
+98
+0.6% +$13K 0.33% 75
2024
Q1 		$2.08M Buy
16,223
+1,017
+7% +$121K 0.31% 80
2023
Q4 		$1.57M Buy
15,206
+5,000
+49% +$494K 0.34% 69
2023
Q3 		$928K Sell
10,206
-4,000
-28% -$352K 0.21% 125
2023
Q2 		$1.15M Hold
14,206
– – 0.24% 119
2023
Q1 		$1.13M Sell
14,206
-2,000
-12% -$142K 0.25% 111
2022
Q4 		$1.1M Buy
16,206
+8,000
+97% +$469K 0.26% 111
2022
Q3 		$409K Hold
8,206
– – 0.1% 183
2022
Q2 		$457K Hold
8,206
– – 0.1% 185
2022
Q1 		$456K Hold
8,206
– – 0.08% 190
2021
Q4 		$460K Hold
8,206
– – 0.08% 196
2021
Q3 		$394K Hold
8,206
– – 0.07% 207
2021
Q2 		$344K Buy
8,206
+1,124
+16% +$43.6K 0.06% 211
2021
Q1 		$239K Hold
7,082
– – 0.05% 246
2020
Q4 		$247K Hold
7,082
– – 0.05% 236
2020
Q3 		$246K Hold
7,082
– – 0.06% 225
2020
Q2 		$232K Hold
7,082
– – 0.06% 219
2020
Q1 		$213K Hold
7,082
– – 0.07% 198
2019
Q4 		$205K Buy
+7,082
New +$196K 0.05% 217
2016
Q1 		– Sell
-7,000
Closed -$203K – 210
2015
Q4 		$203K Buy
+7,000
New +$194K 0.07% 180

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Aviance Capital Partners's NVO Position: Q1 2026 in Review

Aviance Capital Partners reduced its Novo Nordisk (NVO) stake by 1% in Q1 2026, selling an estimated $4.83K and leaving 10,086 shares worth $371K. The position accounts for 0.04% of the portfolio, ranked #278.

Aviance Capital Partners first reported a position in NVO in Q4 2015 and has held it in 27 quarters since. The position peaked at $3.13M in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Aviance Capital Partners held 10,086 shares of Novo Nordisk worth $371K as of Q1 2026.
  • Aviance Capital Partners sold 102 Novo Nordisk shares in Q1 2026, an estimated $4.83K.
  • Novo Nordisk made up 0.04% of Aviance Capital Partners's portfolio in Q1 2026, its #278 holding.
  • Aviance Capital Partners first reported a position in Novo Nordisk in Q4 2015 and has held it in 27 quarters since.
  • Aviance Capital Partners's Novo Nordisk position peaked at $3.13M in Q2 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.